Aptose Biosciences Inc. is a clinical-stage biotechnology company. The company is advancing therapeutics to treat life-threatening cancers, such as acute myeloid 5 May 2020 Stock Market News. Profile. Aptose Biosciences, Inc. Subscribe via RSS · Subscribe 18 May 2020 Aptose Biosciences Inc. (NASDAQ:APTO) has seen 1,052,091 shares traded in the last trading session. The company, currently valued at Stock screener for investors and traders, financial visualizations. Aptose Biosciences Inc. (Aptose) is a clinical-stage biotechnology company. The Company is engaged in the development of anticancer drugs that target 21 Nov 2019 The flip side of that is that there are more than a few examples of insiders dumping stock prior to a period of weak performance. So before you buy Aptose Biosciences. Inc. (US:APTO) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position
APTO股票價格和圖表 — NASDAQ:APTO — TradingView 查看即時aptose biosciences inc圖表以追踪其股票的價格行為。查找市場預測，apto財務和市場新聞。 APTO - Aptose Biosciences Inc. - 相關新聞 | 美股 | Anue鉅亨
Aptose Biosciences Inc. Home; About. Overview; Management Team; Board of Directors; Scientific Advisory Board Aptose Biosciences Inc. (APTO) Aptose Biosciences is a science-driven clinical-stage biotechnology company developing first-in-class targeted agents to address the unmet clinical need in chronic lymphocytic leukemia (CLL), non-Hodgkin’s lymphoma (NHL), acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and other hematologic malignancies.
APTO:NASDAQ CM Stock Quote - Aptose Biosciences Inc ... Stock analysis for Aptose Biosciences Inc (APTO:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. APS Stock Price | Aptose Biosciences Inc. Stock Quote ... Aptose Biosciences Inc. Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. APTO股票價格和圖表 — NASDAQ:APTO — TradingView
Aptose Biosciences, Inc. - 財經百科 - 財經知識庫 - MoneyDJ理財網 Aptose Biosciences, Inc.(APTO.US)為一家臨床階段的抗腫瘤公司，專注於開拓標靶治療及伴隨診斷，主要係提供一種新的途徑誘導細胞凋亡(計畫性細胞死亡 APTOSE BIOSCIENCES INC (APS.TO) stock price, quote ... Aptose to Present Early CG-806 Clinical Findings at the 25th Congress of the European Hematology Association. SAN DIEGO and TORONTO, May 14, 2020 -- Aptose Biosciences Inc. (“Aptose” or the